UPDATE: JP Morgan Upgrades Teva Pharmaceuticals By: Benzinga via Benzinga March 14, 2014 at 12:11 PM EDT On Friday, JP Morgan upgraded shares of Teva Pharmaceuticals (NYSE: TEVA) from Underweight to Neutral and raised the profit target to ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR